Outlook Therapeutics Inc. (NASDAQ: OTLK) Stock Information | RedChip

Outlook Therapeutics Inc. (NASDAQ: OTLK) Listen to this Section


$7.69
+0.0100 ( +0.13% ) 197.7K

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.

Market Data


Open


$7.69

Previous close


$7.68

Volume


197.7K

Market cap


$180.46M

Day range


$7.48 - $8.06

52 week range


$4.00 - $29.20

Insider Ownership Transactions

Total Amount Purchased: -420,450.00 | $ -3,233,260.50

Date Type Amount Purchased Purchaser
2023-10-05 Sale -210225.00 Auffarth Gerd
2023-10-05 Sale -210225.00 Haller Julia A

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Mar 18, 2024
4 Insider transactions 1 Mar 11, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024
4 Insider transactions 1 Mar 08, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.